Essex Financial Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Buy
5,177
+318
+7% +$17.3K 0.01% 762
2026
Q1
$305K Buy
4,859
+2,294
+89% +$184K 0.02% 608
2025
Q4
$245K Sell
2,565
-241
-9% -$23.6K 0.01% 677
2025
Q3
$274K Buy
2,806
+56
+2% +$5.8K 0.02% 605
2025
Q2
$295K Sell
2,750
-227
-8% -$23K 0.02% 552
2025
Q1
$300K Buy
2,977
+356
+14% +$35.8K 0.02% 496
2024
Q4
$234K Buy
2,621
+303
+13% +$26.7K 0.02% 560
2024
Q3
$204K Buy
+2,318
New +$183K 0.01% 598

Other funds holding BSX

Essex Financial Services's BSX Position: Q2 2026 in Review

Essex Financial Services increased its Boston Scientific (BSX) stake by 6.5% in Q2 2026, buying an estimated $17.3K and bringing the position to 5,177 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #762.

Essex Financial Services first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $305K in Q1 2026. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Essex Financial Services held 5,177 shares of Boston Scientific worth $221K as of Q2 2026.
  • Essex Financial Services bought 318 Boston Scientific shares in Q2 2026, an estimated $17.3K.
  • Boston Scientific made up 0.01% of Essex Financial Services's portfolio in Q2 2026, its #762 holding.
  • Essex Financial Services first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
  • Essex Financial Services's Boston Scientific position peaked at $305K in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Essex Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.